Optofluidic ARROW Waveguides for Amplification-Free Nucleic Acid Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current nucleic acid testing methods, such as real-time PCR, require skilled operators, expensive reagents, and controlled environments due to the need for amplification of viral nucleic acids to generate detectable signals, limiting the development of rapid, sensitive, and reliable diagnostic instruments for viral detection.
Innovation Solution
A planar optofluidic platform utilizing hollow-core antiresonant reflecting optical waveguides (ARROWs) for optical particle detection, enabling the detection of fluorescently labeled nucleic acids from small sample volumes without amplification, interfacing with standard fiber optics and microfluidics for sensitive and specific detection of nucleic acids.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If real-time PCR amplification is used to generate detectable signals, then detection sensitivity is improved, but device complexity and operational difficulty increase due to requiring skilled operators and controlled environments
Solution Approach 1:
The patent extracts and eliminates the amplification step from the nucleic acid detection process. By using hollow-core ARROW waveguides with enhanced evanescent field interaction, the system achieves sufficient signal detection directly from native nucleic acids without requiring PCR amplification, thereby removing the associated operational complexity and infrastructure requirements
Solution Approach 2:
The patent changes the optical detection parameters by using hollow-core ARROW waveguides that provide enhanced light-matter interaction through their unique evanescent field confinement. This parameter change in the optical detection mechanism enables sufficient sensitivity without amplification, resolving the contradiction between detection sensitivity and operational simplicity
2Measurement precision
If real-time PCR amplification is used to generate large enough signals, then signal detectability is improved, but detection time and cost increase due to amplification requirements
Solution Approach 1:
The patent removes the time-consuming amplification step from the detection workflow. By achieving sufficient signal detectability through enhanced optical interaction in hollow-core ARROW waveguides, the system enables direct detection of nucleic acids without the hours required for PCR cycling, significantly reducing detection time
Solution Approach 2:
The patent skips the amplification phase entirely and rushes directly to detection by using optimized optical waveguide structures that provide sufficient signal enhancement in a single pass, eliminating the iterative heating and cooling cycles of PCR and enabling rapid point-of-care testing
3Measurement precision
If amplification reagents are used to generate detectable signals, then signal strength is improved, but reagent cost and environmental control requirements increase
Solution Approach 1:
The patent extracts and eliminates the need for expensive amplification reagents (primers, probes, enzymes) by using a label-free or minimal-label optical detection approach with hollow-core ARROW waveguides. The enhanced evanescent field interaction provides sufficient signal strength from native nucleic acids, removing the requirement for costly reagent kits
Solution Approach 2:
The hollow-core ARROW waveguide structure provides self-enhancement of the optical signal through its unique physics-based evanescent field confinement. This self-service mechanism generates sufficient signal strength intrinsically without requiring external amplification reagents, enabling cost-effective detection
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The optofluidic platform achieves highly sensitive and specific detection of nucleic acids, including single virus particles and strains, without the need for advanced microscopy, facilitating rapid and reliable point-of-care viral analysis in clinical and biomedicine settings.
Implementation Method 1
hollow-core antiresonant reflecting optical waveguides (ARROWs)
Implementation Method 2
antiresonant reflecting optical waveguides
Implementation Method 3
fluorophore attached to a nucleic acid
Data Source
AI summary
An optofluidic platform is constructed so as to comprise a planar, liquid-core integrated optical waveguides for specific detection of nucleic acids. Most preferably, the optical waveguides comprises antiresonant reflecting optical waveguide (ARROWs). A liquid solution can be prepared and introduced into the optofluidic platform for optical excitation. The resulting optical signal can be collected at the edges of the optofluidic platform and can be analyzed to determine the existence of a single and/or a specific nucleic acid.